These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9631988)

  • 21. Therapies for onychomycosis: a review.
    Gupta AK; Tu LQ
    Dermatol Clin; 2006 Jul; 24(3):375-9. PubMed ID: 16798436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail.
    Rich P; Scher RK; Breneman D; Savin RC; Feingold DS; Konnikov N; Shupack JL; Pinnell S; Levine N; Lowe NJ; Aly R; Odom RB; Greer DL; Morman MR; Bucko AD; Tschen EH; Elewski BE; Smith EB; Hilbert J
    J Am Acad Dermatol; 1998 Jun; 38(6 Pt 2):S103-9. PubMed ID: 9631992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluconazole (Fungolon) in the treatment of onychomycoses.
    Zisova LG
    Folia Med (Plovdiv); 2004; 46(3):47-50. PubMed ID: 15819457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New treatments of onychomycoses].
    Baran R
    Ann Dermatol Venereol; 1992; 119(3):227-31. PubMed ID: 1318667
    [No Abstract]   [Full Text] [Related]  

  • 25. [The modern approach to the treatment for onychomycosis of hands and feet in the outpatient setting].
    Gerasimchuk EV; Gerasimov VV; Molchanov BA
    Voen Med Zh; 2005 Nov; 326(11):44-5. PubMed ID: 16404907
    [No Abstract]   [Full Text] [Related]  

  • 26. Fungal nail infections (onychomycosis): a never-ending story?
    Ghannoum M; Isham N
    PLoS Pathog; 2014 Jun; 10(6):e1004105. PubMed ID: 24901242
    [No Abstract]   [Full Text] [Related]  

  • 27. Emerging therapeutic agents for onychomycosis.
    Piérard GE; Arrese JE; Quatresooz P; Piérard-Franchimont C
    Expert Opin Emerg Drugs; 2007 Sep; 12(3):345-53. PubMed ID: 17874965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Onychomycosis : a crown jewel of dermatology].
    Tietz HJ; Nenoff P
    Hautarzt; 2012 Nov; 63(11):842-7. PubMed ID: 23064669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Why should we treat onychomycosis with patience and perseverance? How can we overcome therapeutic failure?].
    Arrese JE; Piérard GE
    Rev Med Liege; 2000 May; 55(5):438-42. PubMed ID: 10941310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The topical treatment of onychomycosis using a new combined urea/imidazole preparation.
    Hay RJ; Roberts DT; Doherty VR; Richardson MD; Midgley G
    Clin Exp Dermatol; 1988 May; 13(3):164-7. PubMed ID: 2977574
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical inquiries. Which oral antifungal is best for toenail onychomycosis?
    Hinojosa JR; Hitchcock K; Rodriguez JE
    J Fam Pract; 2007 Jul; 56(7):581-2. PubMed ID: 17605954
    [No Abstract]   [Full Text] [Related]  

  • 32. The systemic treatment of onychomycosis.
    Wenig JA
    Clin Podiatr Med Surg; 1995 Apr; 12(2):263-74. PubMed ID: 7600500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. British Association of Dermatologists' guidelines for the management of onychomycosis 2014.
    Ameen M; Lear JT; Madan V; Mohd Mustapa MF; Richardson M
    Br J Dermatol; 2014 Nov; 171(5):937-58. PubMed ID: 25409999
    [No Abstract]   [Full Text] [Related]  

  • 34. Single dose treatment of fungal nail disease.
    Shuster S; Munro CS
    Lancet; 1992 Apr; 339(8800):1066. PubMed ID: 1349100
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (Diflucan) in the treatment of patients with toenail onychomycosis.
    Salo H; Pekurinen M
    Pharmacoeconomics; 2002; 20(5):319-24. PubMed ID: 11994041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on current approaches to diagnosis and treatment of onychomycosis.
    Gupta AK; Mays RR; Versteeg SG; Shear NH; Piguet V
    Expert Rev Anti Infect Ther; 2018 Dec; 16(12):929-938. PubMed ID: 30411650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of onychomycosis].
    Suhonen R; Karvonen J
    Duodecim; 1998; 22(114):2343-50. PubMed ID: 11757097
    [No Abstract]   [Full Text] [Related]  

  • 39. [Intermittent-pulse treatment of onychomycosis with orally administered itraconazole].
    Yan L; Wen H; Zhong Y; Cao C
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):71-3. PubMed ID: 11938747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of bifonazole urea in the two-phase treatment of onychomycosis.
    Bonifaz A; Guzmán A; Garcia C; Sosa J; Saúl A
    Int J Dermatol; 1995 Jul; 34(7):500-3. PubMed ID: 7591419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.